Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Elena Laudani
Observed names:
Laudani, Maria Elena,
M. Laudani,
MARIA ELENA LAUDANI,
Maria E. Laudani
Institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Ospedale Sant'Anna,
European Institute of Oncology
Observed institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Ospedale Sant'Anna,
Ospedale Sant'Anna,
University of Turin,
European Institute of Oncology
ORCID:
0000-0003-2865-7939
Observed ORCID:
0000-0003-2865-7939
OpenAlex ID:
A5012619778
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
2024
·
Nicoletta Colombo
, Elena Biagioli
, et al.
·
The Lancet Oncology
·
164
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer
2023
·
Lara Paracchini
, Laura Mannarino
, et al.
·
Science Translational Medicine
·
27
PDF
Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer
2020
·
Enrico Potenza
, Giulia Parpinel
, et al.
·
The International Journal of Biological Markers
·
26
PDF
Use of Positron Emission Tomography for Pregnancy-Associated Cancer Assessment: A Review
2022
·
Giulia Parpinel
, Maria Elena Laudani
, et al.
·
Journal of Clinical Medicine
·
25
PDF
Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment: A Multicenter Retrospective Italian Study
2022
·
ANGIOLO GADDUCCI
, STEFANIA COSIO
, et al.
·
Anticancer Research
·
25
PDF
The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
2023
·
Giulia Parpinel
, Maria Elena Laudani
, et al.
·
Cancer Control
·
15
COVID-19 in Pregnancy: Influence of Body Weight and Nutritional Status on Maternal and Pregnancy Outcomes—A Review of Literature and Meta-Analysis
2023
·
Rossella Attini
, Maria Elena Laudani
, et al.
·
Nutrients
·
9
PDF
Effect of Depressive Disorders and Their Pharmacological Treatment during Pregnancy on Maternal and Neonatal Outcome
2022
·
Giulia Parpinel
, Gianluca Rosso
, et al.
·
Journal of Clinical Medicine
·
9
PDF
Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial
2025
·
Benoit You
, Charles Anderson
, et al.
·
Gynecologic Oncology
·
7
PDF
Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging
2024
·
Tullio Golia D'Augè
, Giuseppe Caruso
, et al.
·
International Journal of Gynecological Cancer
·
4
Impact of different follow-up regimens on health-related quality of life and costs in endometrial cancer patients: Results from the TOTEM randomized trial
2024
·
Rosalba Rosato
, Annamaria Ferrero
, et al.
·
Gynecologic Oncology
·
4
PDF
562 Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial
2024
·
Benoit You
, Charles Anderson
, et al.
·
International Journal of Gynecological Cancer
·
3
1252 Update on the role of intraoperative indocyanine green fluorescence angiography in preventing anastomotic leakage after colorectal resection in cytoreductive surgery for advanced ovarian cancer
2024
·
Livia Xhindoli
, Gabriella Schivardi
, et al.
·
International Journal of Gynecological Cancer
·
2
Lymphadenectomy in early-stage ovarian cancer: is there still a role?
2026
·
Giuseppe Caruso
, Susanna Delfrati
, et al.
·
International Journal of Gynecological Cancer
·
1
O025/#522 Maintenance olaparib rechallenge in patients with ovarian cancer previously treated with a parp inhibitor: patient-reported outcomes from the phase IIIB OReO/engot-ov38 trial
2022
·
Andrés Redondo
, Philippe Follana
, et al.
·
International Journal of Gynecological Cancer
·
1
PDF
Breast Cancer and Pregnancy
2022
·
P. Zola
, C. Macchi
, et al.
·
BENTHAM SCIENCE PUBLISHERS eBooks
·
1
Fifteen-year practice trends and oncologic outcomes of early-stage cervical cancer
2026
·
Giuseppe Caruso
, Filippo Casaccia Giordano
, et al.
·
European Journal of Surgical Oncology
Regional Audit and Feedback Intervention to Improve Quality of Care in Ovarian Cancer Treatment: The Easy-Net Experience
2026
·
Elisa Piovano
, Annamaria Ferrero
, et al.
·
JCO Oncology Practice
Real-Life Feasibility Of Multiple-Drugs Regimens Including Pembrolizumab In The Treatment Of Persistent, Recurrent Or Metastatic Cervical Cancer
2025
·
Elisa Piovano
, Elena Casetta
, et al.
·
International Journal of Gynecological Cancer
Systemic Immune Inflammation Index: An Actionable Tool For Early Detection Of The Relapse During Maintenance With PARPi In Ovarian Cancer Patients
2025
·
Elisa Piovano
, Maria Pia Chiparo
, et al.
·
International Journal of Gynecological Cancer
PDF
Benefit from the Immune Checkpoint Inhibitor Atezolizumab Addition in Poor Prognostic Ovarian Cancer Patients : Imagyn050 Trial
2025
·
Benoit You
, Charles Anderson
, et al.
·
SSRN Electronic Journal
580 A regional audit & feedback intervention to improve quality of care in ovarian cancer treatment. The easy-net experience
2024
·
Elisa Piovano
, Eva Pagano
, et al.
·
International Journal of Gynecological Cancer
578 Ca125, HE4 and systemic immune inflammation index during maintenance with PARPi in ovarian cancer patients: three markers, two markers, or usual ca125?
2024
·
Elisa Piovano
, Fulvio Borella
, et al.
·
International Journal of Gynecological Cancer
1109 Para-aortic lymph node recurrence in surgically treated apparent early-stage cervical cancer: experience from a tertiary referral cancer center
2024
·
Tullio Golia D’Augè
, Gabriella Schivardi
, et al.
·
International Journal of Gynecological Cancer
577 Impact of different follow-up regimens on health-related quality of life and costs in endometrial cancer patients: results from the TOTEM randomized trial
2024
·
Rosalba Rosato
, Annamaria Ferrero
, et al.
·
International Journal of Gynecological Cancer
Show more works
View as search
Works count:
36
Citation count:
323
H-index:
8
I10-index:
6
Year
Topic
Type